中國船舶(600150.SH):廣船國際擬轉讓中山公司51%的股權
格隆匯11月13日丨中國船舶(600150.SH)公佈,為進一步改善經營狀況,提高資源配置效率,發揮整體協同效應,公司控股子公司廣船國際擬向中船投資轉讓其全資子公司中山公司51%的股權,轉讓價格為人民幣6.45億元。
本次股權轉讓將導致上市公司合併報表範圍變更,股權轉讓完成後,中山公司將不再納入公司報表範圍,其長期虧損問題將妥善解決。同時廣船國際通過盤活土地資產取得增值收益,預計可藉此回收約6.45億元現金用於減少財務費用支出,將極大改善其年度經營業績。
此次股權轉讓完成後,預計將增加公司歸屬於母公司的淨利潤約4.3億元(以最終年度審計結果為準),有利於進一步改善本公司經營狀況。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.